Not my exact words (you rephrased the question slightly), but thanks for answering it - sort of.
You have no idea why they will not be able to send FluCide for tox testing (versus prior claims that you know and they know that they CAN NEVER produce enough). It is just pure speculation on your part that they can't. Your current theory seems to be that they really still can't produce enough FluCide, even though they can now produce enough nanomicelles. You hint that there is a problem with the FluCide ligand production or ligand attachment, but won't come out and say it.
I believe they will be sending FluCide for toxicity testing before too long, and don't see anything that would stop them from doing so. Some possible reasons for not doing it expeditiously:
(1) they can't yet produce the FluCide from nanomicelles, perhaps related to inability to produce FluCide ligands at scale, inability to combine FluCide ligands and nanomicelles at scale, inability to characterize the final FluCide product, etc...
(2) they are saving the 500g batches of nanomicelles for something else of higher priority, perhaps more pre-clinical studies of the various HerpeCides.
(3) they are saving money by not sending FluCide for tox testing just yet, since they want to focus instead on topical HerpeCide, which might have an easier and faster path to market and revenue.
(4) your and others' conspiracy theory - that they know they can never make and show these nanoviricides will work safely in humans, they are keeping the reason(s) secret, and they are stalling all development just so they can collect a salary.
Just curious if you had any "insight" / inside information into your repeated claims that they CAN NEVER produce enough of any nanoviricide to complete toxicity testing, especially since now the 500g batch nanomicelle hurdle has been cleared. I guess not. You don't really know this. You are speculating without any valid reasons, despite claims of inside information.
